Terushkin focuses on evidence-based obesity treatment, GLP-1 therapy, and long-term metabolic outcomes with an emphasis on patient safety and clinical excellence
Murugesan A, Kari S, Shrestha A, Assoah B,Saravanan KM,Murugesan M, Thiyagarajan R, Candeias NR,Kandhavelu M
In this Review, we highlight the latest advances in our understanding of the mechanisms of action of metformin and discuss potential emerging novel therapeutic uses
Clinical Response: Doctors might change the dose based on how well the patient is doing
And yet, Ive opted outnot because I feel sanctimonious about pursuing my weight-loss goals without medication (which I am), or because I think taking GLP-1s is somehow cheating or taking the easy way out (I dont, and its not), but because even though doctors have suggested I try the drugs, Im concerned about certain effects of a treatment thats only become mainstream for weight loss fairly recently